Complaint upheld against advertising of NeuroAD as Alzheimer ’s disease treatment

The Advertising Standards Agency (ASA) have upheld a complaint made against Neuronix for their advertising of a medical device in relation to Alzheimer's disease.
Source: Alzheimers Society - Category: Geriatrics Source Type: news